Subscribe FREE to: Magazine | Newsletter | Linked In | Twitter Facebook

ODT Magazine


Subscribe to ODT Magazine News via RSS

October 24:
Bacterin Releases New Demineralized Allograft Cortical Fibers
Product is first release from new 3Demin line.

Former Mayo Clinic Executive Joins RTI Surgical's Board
New director is advisor to several health organizations.

Globus Medical Buys Allograft Tissue Processing Company
Deal terms were not disclosed.

Australia Proposes Domestic Device Registration Using European CE Marking
Initiative is a new effort to reduce Australia's regulatory burdens.

Report Finds FDA Approving New High-Risk Devices at Fastest Pace in the Last Decade
In 2012, FDA approved high-risk devices through its PMA process in 297 days.

October 23:
Jury Sides with DePuy in First Case About Pinnacle MOM Hips
Case if first of more than 6,600 federal lawsuits.

View all >>>

The Odd Ones Out
Differentiating themselves has helped testing service providers address specific needs in the orthopedic sector, while creating targeted offerings OEM clients never even knew they needed.
By Ranica Arrowsmith

More Speed, Fewer Steps
OEMs want machining and tooling solutions that reduce cycle times and save money. And, by the way they wanted it all yesterday.
By Mark Crawford

Thinking Small
The promise of nanotechnology could potentially lead to new classes of medical devices and pharmaceuticals.
By Michael Barbella

Bioventus Buys Allograft Product Line from Advanced Biologics

ODT interviews Henry Tung, M.D., head of the new Surgical Orthobiologics group of Bioventus.
By Christopher Delporte, Editorial Director

Copyright © 2014 Rodman Media. All Rights Reserved. All rights reserved. Use of this constitutes acceptance of our Privacy Policy
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.